Yabu Y, Miyai K, Kobayashi A, Miki K, Doi K, Takamatsu J, Mozai T, Matsuzuka F, Kuma K
J Endocrinol Invest. 1987 Apr;10(2):163-9. doi: 10.1007/BF03347183.
A new type of serum albumin, that shows a markedly enhanced binding activity for 3,3', 5-triiodothyronine (T3), a somewhat increased activity for thyroxine (T4), and a normal activity for 3,3', 5-triiodothyronine (rT3) is described. This albumin was found in a patient with Graves' disease. After successful subtotal thyroidectomy, the existence of abnormal binding activity for T3 was suspected in this patient because of persistently increased total T3 concentrations in spite of elevated thyrotropin levels. Although free T3 and T4 concentrations measured by radioimmunoassay using commercial tracer analogue kits were markedly increased, those measured by equilibrium dialysis were within normal ranges. Electrophoretic studies revealed that these abnormalities were due to the markedly increased T3 binding activity by the serum albumin; that for T4 was also slightly increased. Scatchard plot analysis revealed that the association constant (Ka) for T3 of the patient's albumin was 5.1 X 10(6)/M (normal pooled albumin; 6.2 X 10(5)/M), and those for T4 and rT3 were 5.2 X 10(6)/M and 2.7 X 10(6)/M, respectively (normal pooled albumin; 2.1 X 10(6)/M for both T4 and rT3). The increased binding of albumin to T3 and T4 was markedly inhibited by barbitone, and 8-anilino-1-naphthalene-sulfonic acid. These characteristic features, and erroneously high values of free T3 and T4 concentrations measured by tracer analogue kits were similar to those seen in patients with familial dysalbuminemic hyperthyroxinemia, which have been previously reported. These findings strongly suggest that this albumin is a new variant in various dysalbuminemic syndromes, and the abnormal binding of iodothyronines moieties in these syndromes are not biochemically identical.
描述了一种新型血清白蛋白,它对3,3',5-三碘甲状腺原氨酸(T3)的结合活性显著增强,对甲状腺素(T4)的活性略有增加,对3,3',5-三碘甲状腺原氨酸(反T3,rT3)的活性正常。这种白蛋白在一名格雷夫斯病患者中被发现。在成功进行甲状腺次全切除术后,尽管促甲状腺素水平升高,但该患者总T3浓度持续升高,因此怀疑其存在对T3的异常结合活性。虽然使用商业示踪剂类似物试剂盒通过放射免疫测定法测得的游离T3和T4浓度显著升高,但通过平衡透析测得的浓度在正常范围内。电泳研究表明,这些异常是由于血清白蛋白对T3的结合活性显著增加所致;对T4的结合活性也略有增加。Scatchard图分析显示,患者白蛋白对T3的缔合常数(Ka)为5.1×10(6)/M(正常混合白蛋白;6.2×10(5)/M),对T4和rT3的缔合常数分别为5.2×10(6)/M和2.7×10(6)/M(正常混合白蛋白;T4和rT3均为2.1×10(6)/M)。巴比妥和8-苯胺基-1-萘磺酸可显著抑制白蛋白与T3和T4的结合增加。这些特征,以及使用示踪剂类似物试剂盒测得的游离T3和T4浓度的错误高值,与先前报道的家族性异常白蛋白血症性甲状腺素过多症患者所见相似。这些发现强烈表明,这种白蛋白是各种异常白蛋白血症综合征中的一种新变体,并且这些综合征中碘甲状腺原氨酸部分的异常结合在生化上并不相同。